Compare, Analyse ASTRAZENECA PHARMA with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ASTRAZENECA PHARMA     Change

AstraZeneca Pharma India Limited (APIL) is a 90% subsidiary of the UK based AstraZeneca Pharmaceuticals, which is one of the world's leading pharma companies. APIL has interests in the six crucial areas of cardiovascular, respiratory, maternal health... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ASTRAZENECA PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-18
ADCOCK INGRAM
Jun-14
ASTRAZENECA PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs1,278373-   
Low Rs883269-   
Sales per share (Unadj.) Rs228.4111.1-  
Earnings per share (Unadj.) Rs10.4-28.0-  
Cash flow per share (Unadj.) Rs16.3-23.2-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs98.887.2-  
Shares outstanding (eoy) m25.00168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.72.9 163.5%   
Avg P/E ratio x104.2-11.5 -907.8%  
P/CF ratio (eoy) x66.4-13.9 -479.5%  
Price / Book Value ratio x10.93.7 296.7%  
Dividend payout %00-   
Avg Mkt Cap Rs m27,00854,239 49.8%   
No. of employees `0001.44.3 31.6%   
Total wages/salary Rs m1,5353,404 45.1%   
Avg. sales/employee Rs Th4,210.94,366.6 96.4%   
Avg. wages/employee Rs Th1,132.2793.0 142.8%   
Avg. net profit/employee Rs Th191.1-1,100.3 -17.4%   
INCOME DATA
Net Sales Rs m5,71018,746 30.5%  
Other income Rs m123131 93.3%   
Total revenues Rs m5,83318,877 30.9%   
Gross profit Rs m463-3,249 -14.2%  
Depreciation Rs m147809 18.2%   
Interest Rs m0508 0.0%   
Profit before tax Rs m438-4,434 -9.9%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m179277 64.6%   
Profit after tax Rs m259-4,724 -5.5%  
Gross profit margin %8.1-17.3 -46.8%  
Effective tax rate %40.8-6.2 -653.7%   
Net profit margin %4.5-25.2 -18.0%  
BALANCE SHEET DATA
Current assets Rs m3,20913,730 23.4%   
Current liabilities Rs m2,0707,725 26.8%   
Net working cap to sales %20.032.0 62.3%  
Current ratio x1.61.8 87.2%  
Inventory Days Days72111 65.2%  
Debtors Days Days35124 28.2%  
Net fixed assets Rs m7908,003 9.9%   
Share capital Rs m5087 57.4%   
"Free" reserves Rs m2,4190-   
Net worth Rs m2,46914,714 16.8%   
Long term debt Rs m05,171 0.0%   
Total assets Rs m4,60527,795 16.6%  
Interest coverage xNM-7.7-  
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x1.20.7 183.8%   
Return on assets %5.6-15.2 -37.1%  
Return on equity %10.5-32.1 -32.7%  
Return on capital %17.7-19.8 -89.5%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-1,7150-   
CASH FLOW
From Operations Rs m881,600 5.5%  
From Investments Rs m-94-491 19.1%  
From Financial Activity Rs mNA4,693 0.0%  
Net Cashflow Rs m-65,801 -0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.15 Rs / ZAR

Compare ASTRAZENECA PHARMA With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare ASTRAZENECA PHARMA With: STRIDES PHARMA SCIENCE  LUPIN  FULFORD INDIA  NOVARTIS  SUVEN LIFE SCIENCES  



Today's Market

Sensex Zooms 661 Points, Nifty Ends Above 14,500; M&M and Bajaj Finserv Top Gainers(Closing)

Indian share markets witnessed most of the buying interest during closing hours today and ended on a strong note.

Related Views On News

ASTRAZENECA PHARMA Announces Quarterly Results (3QFY21); Net Profit Down 21.2% (Quarterly Result Update)

Feb 11, 2021 | Updated on Feb 11, 2021

For the quarter ended December 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 211 m (down 21.2% YoY). Sales on the other hand came in at Rs 2 bn (down 10.5% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY21); Net Profit Down 13.4% (Quarterly Result Update)

Sep 22, 2020 | Updated on Sep 22, 2020

For the quarter ended June 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 186 m (down 13.4% YoY). Sales on the other hand came in at Rs 2 bn (down 5.4% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games? (The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave (Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

If the Market Falls, I Will Do This... (Fast Profits Daily)

Apr 1, 2021

What should you do if the market falls? In this video, I'll tell you what I will do.

The Indian Real Estate Party Has Just Begun (Profit Hunter)

Apr 1, 2021

A favourable demand supply scenario makes a strong case for real estate prices.

The Dilemma of Investing in Bharti Airtel Views On News (Views On News)

Apr 1, 2021

Rahul Shah on whether Bharti Airtel will emerge as the next big thing in the Indian stock market

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

India's Revival: A Once-in-a-generation Wealth Making Opportunity
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

ASTRAZENECA PHARMA SHARE PRICE


Apr 13, 2021 (Close)

TRACK ASTRAZENECA PHARMA

  • Track your investment in ASTRAZENECA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ASTRAZENECA PHARMA

ASTRAZENECA PHARMA 8-QTR ANALYSIS

COMPARE ASTRAZENECA PHARMA WITH

FEATURED VIDEOS

It's a Great Time to Buy Gold

The Dilemma of Investing in Bharti Airtel

Nifty: Bear Trap?

Kalyan Jewellers IPO: An Honest View

More Featured Videos

MARKET STATS